Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms IMIDAS
- 01 Jul 2018 Results published in the Cancer Science.
- 06 Dec 2016 Results assessing the efficacy and safety of dasatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology